ELISA Measurement of Specific Non-antigen-bound Antibodies to Ab1-42 Monomer and Soluble Oligomers in Sera from Alzheimer's Disease, Mild Cognitively Impaired, and Noncognitively Impaired Subjects

Simple item page
dc.contributor.authorKlaver, Andrea C.
dc.contributor.authorCoffey, Mary P.
dc.contributor.authorSmith, Lynnae M.
dc.contributor.authorBennett, David A.
dc.contributor.authorFinke, John M.
dc.contributor.authorDang, Loan
dc.contributor.authorLoeffler, David A.
dc.date.accessioned2025-10-20T19:03:06Z
dc.date.available2025-10-20T19:03:06Z
dc.date.issued1/1/2011
dc.description.abstractThe article presents a study for enzyme-linked immunosorbent assay (ELISA) measurement of specific non-antigen-bound antibodies to Aβ1-42 monomer and soluble oligomers in Alzheimer's disease (AD), mild cognitively impaired (MCI), and noncognitively impaired (NCI) sera. In the study, serum samples were obtained from the Rush Alzheimer's Disease Center, Chicago, Illinois.
dc.identifier.doi10.1186/1742-2094-8-93
dc.identifier.urihttps://hdl.handle.net/1773/54357
dc.publisherJournal of Neuroinflammation
dc.titleELISA Measurement of Specific Non-antigen-bound Antibodies to Ab1-42 Monomer and Soluble Oligomers in Sera from Alzheimer's Disease, Mild Cognitively Impaired, and Noncognitively Impaired Subjects

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Finke2_.pdf
Size:
734.12 KB
Format:
Adobe Portable Document Format
Download

Collections

Faculty & Staff Publications